Salus Telehealth’s VideoMedicine Mobile Platform Connects Touring Recording Artists with their Personal Physicians Anytime, Anywhere

Salus Telehealth, Inc., a market leader and trusted advisor within the telehealth industry, is partnering with Dreamcatcher Artist Management to provide touring recording artists, including rising country star Mo Pitney, with access to their personal physicians via Salus’ VideoMedicine platform while on the road.Pitney is the first artist represented by Dreamcatcher to have specialized telehealth cameras from Salus installed on his tour bus. The videoconferencing cameras are available to everyone in his band and support crew, enabling them to see their personal physicians at any time during their four-month summer tour.“When you are on tour, it is a crazy schedule,” says Peter Keiser, Partner at Dreamcatcher Artist Management. “You are in a different city almost every night so getting sick can create a lot of problems and make it difficult to stay on our strict schedule. It is especially important for Mo to take care of his voice in order to provide the best possible performance for his fans. The ability to see his doctor anytime he needs to through VideoMedicine from his tour bus certainly gives all of us peace of mind.”“Recording artists have no time to get sick when they are on a busy tour schedule – VideoMedicine helps them proactively manage their health without skipping a beat,” says Paula Guy, CEO of Salus Telehealth. “Now that the telehealth cameras are installed on Mo Pitney’s tour bus, it’s as if his personal physician and those of his crew are all travelling alongside them.”Upon the completion of his U.S. tour, Pitney is planning to embark on a European tour starting later this summer and will bring along the Salus telehealth equipment, as the VideoMedicine platform is fully functional overseas. To access VideoMedicine’s network of healthcare providers anytime, anywhere from your phone, tablet or computer, visit www.videomedicine.com or simply download the app from iTunes or Google Play. Physicians interested in joining the VideoMedicine platform can learn more and register here.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.